Parenteral clindamycin therapy for severe anaerobic infections.
D000038:Abscess / Q000188:drug therapy; D000190:Actinomyces / Q000302:isolation & purification; D000328:Adult; D000693:Anaerobiosis; D001424:Bacterial Infections / Q000188:drug therapy*; D001439:Bacteroides / Q000302:isolation & purification; D002701:Chloramphenicol / Q000627:therapeutic use; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D005673:Fusobacterium / Q000302:isolation & purification; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008826:Microbial Sensitivity Tests; D010460:Peptococcus / Q000302:isolation & purification; D010462:Peptostreptococcus / Q000302:isolation & purification; D010710:Phosphates; D018805:Sepsis / Q000188:drug therapy / Q000401:mortality; D013291:Streptococcus / Q000302:isolation & purification; D014945:Wound Healing
D010710:Phosphates; D002981:Clindamycin; D002701:Chloramphenicol